Dennis Slamon
Dennis Slamon
Dennis Slamon (pronunciation: DEN-iss SLAY-mon) is an American oncologist and researcher known for his work in the development of Herceptin, a drug used for the treatment of breast cancer.
Etymology
The name "Dennis" is of Greek origin, derived from "Dionysius", the god of wine and revelry. "Slamon" is a surname of unknown origin.
Biography
Dennis Slamon was born in Philadelphia, Pennsylvania. He completed his undergraduate studies at the University of Pennsylvania, and later earned his medical degree from the University of Chicago. Slamon is currently a professor of medicine at the University of California, Los Angeles (UCLA), where he also serves as the director of Clinical/Translational Research at the Jonsson Comprehensive Cancer Center.
Contributions to Medicine
Slamon's most significant contribution to medicine is his work on the development of Herceptin. He led the clinical trials that demonstrated the effectiveness of Herceptin in treating breast cancer, particularly in patients with HER2-positive tumors. This discovery has revolutionized the treatment of breast cancer and has saved countless lives.
Related Terms
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Herceptin: A drug used for the treatment of breast cancer.
- Breast Cancer: A type of cancer that forms in the cells of the breasts.
- HER2-positive: A term used to describe a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells.
External links
- Medical encyclopedia article on Dennis Slamon
- Wikipedia's article - Dennis Slamon
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski